ESTRO37_ProgrammeBook

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

SATURDAY 21 APRIL 2018

> Stereotactic body radiotherapy treatment for hepatocellular carcinoma: A phase II study J. Durand-Labrunie (France), H. Jarraya, E. Boleslawski, S. Cattan, T. Lacornerie, D. Peiffert, X. Mirabel > Liver-directed CCRT with high-dose radiation is effective in BCLC-C hepatocellular carcinoma H.K. Byun (Republic of Korea), H.J. Kim, J. Seong

PV-0105

PV-0106

PRESIDENTIAL SYMPOSIUM 12:00 - 12:30  | ROOM AUDITORIUM > Re/Mind Value

Speaker: Y. Lievens (Belgium)

SP-0107

AWARD LECTURE Emmanuel van der Schueren Award Lecture 12:30 - 13:00  | ROOM AUDITORIUM Chair: P. Poortmans (France )

12:35 > The ESTRO School - Radiation oncology education of the highest standard for all Speaker: C. Verfaillie (Belgium)

SP-0108

SYMPOSIUM Lung and dose escalation 14:30 - 15:45  | ROOM 116

Dose escalation in non-small cell lung cancer has become a double-sided sword: whereas high-dose hypo-fractionated radiotherapy is well established in stereotactic body radiotherapy for early stages, the transfer to locally advanced stages is discussed controversially. This session will show the long-term results of the RTOG 0617 study and review secondary analyses, which evaluated whether and how dose escalation may still play a role. It will be discussed whether hypo-fractionated delivery of dose escalated radiotherapy is feasible or double-trouble, in particular when combined with systemic treatments. Finally, it will be addressed how to select the patient-individual optimal radiotherapy technology using advanced outcome modelling. Chair: M. Guckenberger (Switzerland) Co-Chair: A. Botticella (France)

Programme and Exhibition Guide | SCIENTIFIC PROGRAMME

85